Betatrophin: The long awaited circulating factor from the liver promoting β-cell replication?

Islets

Volumn 6, Issue 2, 2014, Pages e28686-1-e28686-5

  Ahnfelt Rønne, Jonas ^a   Madsen, Ole D ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

AGNPTL8; Betatrophin; Diabetes; Lipasin; RIFL

Indexed keywords

BETATROPHIN; PROTEIN; SCATTER FACTOR; UNCLASSIFIED DRUG; PEPTIDE HORMONE;

ARTICLE; CELL DIVISION; CELL PROLIFERATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; SIGNAL TRANSDUCTION; TISSUE REGENERATION; ANIMAL; CYTOLOGY; FEMALE; MALE; METABOLISM; PANCREAS;

ANIMALS; CELL PROLIFERATION; FEMALE; HUMANS; INSULIN-SECRETING CELLS; MALE; PANCREAS; PEPTIDE HORMONES;

EID: 84929630678     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.28686     Document Type: Article

References (23)

1. Yi P, Park JS, Melton DA. Betatrophin: a hormone that controls pancreatic ß cell proliferation. Cell 2013; 153:747-58; PMID:23623304; http://dx.doi.org/10.1016/j.cell.2013.04.008.
2. Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler GD, Altschul SF, et al.; Mammalian Gene Collection Program Team. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A 2002; 99:16899-903; PMID:12477932; http://dx.doi.org/10.1073/pnas.242603899.
3. Tang T, Li L, Tang J, Li Y, Lin WY, Martin F, Grant D, Solloway M, Parker L, Ye W, et al. A mouse knockout library for secreted and transmembrane proteins. Nat Biotechnol 2010; 28:749-55; PMID:20562862; http://dx.doi.org/10.1038/nbt.1644.
4. Ren G, Kim JY, Smas CM. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab 2012; 303:E334-51; PMID:22569073; http://dx.doi.org/10.1152/ajpendo.00084.2012.
5. Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun 2012; 424:786-92; PMID:22809513; http://dx.doi.org/10.1016/j.bbrc.2012.07.038.
6. Quagliarini F, Wang Y, Kozlitina J, Grishin NV, Hyde R, Boerwinkle E, Valenzuela DM, Murphy AJ, Cohen JC, Hobbs HH. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci U S A 2012; 109:19751-6; PMID:23150577; http://dx.doi.org/10.1073/pnas.1217552109.
7. Dong XY, Pang XW, Yu ST, Su YR, Wang HC, Yin YH, Wang YD, Chen WF. Identification of genes differentially expressed in human hepatocellular carcinoma by a modified suppression subtractive hybridization method. Int J Cancer 2004; 112:239-48; PMID:15352036; http://dx.doi.org/10.1002/ijc.20363.
8. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010; 466:707-13; PMID:20686565; http://dx.doi.org/10.1038/nature09270.
9. Flier SN, Kulkarni RN, Kahn CR. Evidence for a circulating islet cell growth factor in insulin-resistant states. Proc Natl Acad Sci U S A 2001; 98:7475-80; PMID:11404474; http://dx.doi.org/10.1073/pnas.131192998.
10. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, Kahn CR. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 2000; 6:87-97; PMID:10949030; http://dx.doi.org/10.1016/S1097-2765(00)00010-1.
11. Brüning JC, Michael MD, Winnay JN, Hayashi T, Hörsch D, Accili D, Goodyear LJ, Kahn CR. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 1998; 2:559-69; PMID:9844629; http://dx.doi.org/10.1016/S1097-2765(00)80155-0.
12. Imai J, Katagiri H, Yamada T, Ishigaki Y, Suzuki T, Kudo H, Uno K, Hasegawa Y, Gao J, Kaneko K, et al. Regulation of pancreatic beta cell mass by neuronal signals from the liver. Science 2008; 322:1250-4; PMID:19023081; http://dx.doi.org/10.1126/science.1163971.
13. El Ouaamari A, Kawamori D, Dirice E, Liew CW, Shadrach JL, Hu J, Katsuta H, Hollister-Lock J, Qian WJ, Wagers AJ, et al. Liver-derived systemic factors drive ß cell hyperplasia in insulin-resistant states. Cell Rep 2013; 3:401-10; PMID:23375376; http://dx.doi.org/10.1016/j.celrep.2013.01.007.
14. Gelling RW, Du XQ, Dichmann DS, Romer J, Huang H, Cui L, Obici S, Tang B, Holst JJ, Fledelius C, et al. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci U S A 2003; 100:1438-43; PMID:12552113; http://dx.doi.org/10.1073/pnas.0237106100.
15. Longuet C, Robledo AM, Dean ED, Dai C, Ali S, McGuinness I, de Chavez V, Vuguin PM, Charron MJ, Powers AC, et al. Liver-specific disruption of the murine glucagon receptor produces a-cell hyper-plasia: evidence for a circulating a-cell growth factor. Diabetes 2013; 62:1196-205; PMID:23160527; http://dx.doi.org/10.2337/db11-1605.
16. Araújo TG, Oliveira AG, Carvalho BM, Guadagnini D, Protzek AO, Carvalheira JB, Boschero AC, Saad MJ. Hepatocyte growth factor plays a key role in insulin resistance-associated compensatory mechanisms. Endocrinology 2012; 153:5760-9; PMID:23024263; http://dx.doi.org/10.1210/en.2012-1496.
17. Schäffer L, Brand CL, Hansen BF, Ribel U, Shaw AC, Slaaby R, Sturis J. A novel high-affinity peptide antagonist to the insulin receptor. Biochem Biophys Res Commun 2008; 376:380-3; PMID:18782558; http://dx.doi.org/10.1016/j.bbrc.2008.08.151.
18. Espes D, Lau J, Carlsson PO. Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia 2013; PMID:24078058.
19. Jiao Y, Le LJ, Yu M, Naji A, Kaestner KH. Elevated mouse hepatic betatrophin expression does not increase human beta-cell replication in the transplant setting. Diabetes 2013; PMID:24353178.
20. Gargani S, Thévenet J, Yuan JE, Lefebvre B, Delalleau N, Gmyr V, Hubert T, Duhamel A, Pattou F, Kerr-Conte J. Adaptive changes of human islets to an obesogenic environment in the mouse. Diabetologia 2013; 56:350-8; PMID:23192693; http://dx.doi.org/10.1007/s00125-012-2775-y.
21. Porat S, Weinberg-Corem N, Tornovsky-Babaey S, Schyr-Ben-Haroush R, Hija A, Stolovich-Rain M, Dadon D, Granot Z, Ben-Hur V, White P, et al. Control of pancreatic ß cell regeneration by glucose metabolism. Cell Metab 2011; 13:440-9; PMID:21459328; http://dx.doi.org/10.1016/j.cmet.2011.02.012.
22. Okada T, Liew CW, Hu J, Hinault C, Michael MD, Krtzfeldt J, Yin C, Holzenberger M, Stoffel M, Kulkarni RN. Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci U S A 2007; 104:8977-82; PMID:17416680; http://dx.doi.org/10.1073/pnas.0608703104.
23. Nica AC, Ongen H, Irminger JC, Bosco D, Berney T, Antonarakis SE, Halban PA, Dermitzakis ET. Cell-type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome. Genome Res 2013; 23:1554-62; PMID:23716500; http://dx.doi.org/10.1101/gr.150706.112.